Beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

Ashok Aspatwar; Milka Hammaren; Sanni Koskinen; Bruno Luukinen; Harlan Barker; Fabrizio Carta; Claudiu T. Supuran; Mataleena Parikka; Seppo Parkkila

doi:10.1080/14756366.2017.1332056

Beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

Ashok Aspatwar, Milka Hammaren, Sanni Koskinen, Bruno Luukinen, Harlan Barker, Fabrizio Carta, Claudiu T. Supuran, Mataleena Parikka, Seppo Parkkila

Kliinisen kemian yksikkö

Tutkimustuotos: Artikkeli › Scientific › vertaisarvioitu

30 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	832-840
Julkaisu	JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Vuosikerta	32
Numero	1
DOI - pysyväislinkit	https://doi.org/10.1080/14756366.2017.1332056
Tila	Julkaistu - 2017
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Tutkimusalat

Dithiocarbamates
Mycobacterium marinum
beta-carbonic anhydrase
in vivo inhibition
zebrafish embryos

Julkaisufoorumi-taso

Jufo-taso 1

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

Pääsy asiakirjaan

10.1080/14756366.2017.1332056

http://urn.fi/urn:nbn:fi:uta-201708112261

Siteeraa tätä

Aspatwar, A., Hammaren, M., Koskinen, S., Luukinen, B., Barker, H., Carta, F., Supuran, C. T., Parikka, M., & Parkkila, S. (2017). Beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 32(1), 832-840. https://doi.org/10.1080/14756366.2017.1332056

@article{bb4021e4c4cd4bffa6b4f4537e5ee282,

title = "Beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis",

keywords = "Dithiocarbamates, Mycobacterium marinum, beta-carbonic anhydrase, in vivo inhibition, zebrafish embryos, Dithiocarbamates, Mycobacterium marinum, beta-carbonic anhydrase, in vivo inhibition, zebrafish embryos",

author = "Ashok Aspatwar and Milka Hammaren and Sanni Koskinen and Bruno Luukinen and Harlan Barker and Fabrizio Carta and Supuran, {Claudiu T.} and Mataleena Parikka and Seppo Parkkila",

year = "2017",

doi = "10.1080/14756366.2017.1332056",

language = "English",

volume = "32",

pages = "832--840",

journal = "JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY",

issn = "1475-6366",

publisher = "Informa Healthcare",

number = "1",

}

Aspatwar, A , Hammaren, M, Koskinen, S, Luukinen, B, Barker, H, Carta, F, Supuran, CT, Parikka, M & Parkkila, S 2017, 'Beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis', JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, Vuosikerta 32, Nro 1, Sivut 832-840. https://doi.org/10.1080/14756366.2017.1332056

TY - JOUR

T1 - Beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

AU - Aspatwar, Ashok

AU - Hammaren, Milka

AU - Koskinen, Sanni

AU - Luukinen, Bruno

AU - Barker, Harlan

AU - Carta, Fabrizio

AU - Supuran, Claudiu T.

AU - Parikka, Mataleena

AU - Parkkila, Seppo

PY - 2017

Y1 - 2017

KW - Dithiocarbamates

KW - Mycobacterium marinum

KW - beta-carbonic anhydrase

KW - in vivo inhibition

KW - zebrafish embryos

KW - Dithiocarbamates

KW - Mycobacterium marinum

KW - beta-carbonic anhydrase

KW - in vivo inhibition

KW - zebrafish embryos

U2 - 10.1080/14756366.2017.1332056

DO - 10.1080/14756366.2017.1332056

M3 - Article

SN - 1475-6366

VL - 32

SP - 832

EP - 840

JO - JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

JF - JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IS - 1

ER -